Correlating Lamotrigine Serum Concentrations with Tolerability in Patients with Epilepsy
Neurol 63:1022-1026, Hirsch,L.J.,et al, 2004
Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003
Severe Intoxication After Phenytoin Infusion: A Preventable Pharmacogenetic Adverse Reaction
Neurol 60:1395-1396, Citerio,G.,et al, 2003
Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003
Subtherapeutic Free Phenytoin Levels Following Fosphenytoin Therapy in Status Epilepticus
Neurol 58:147-148, Koul,R. &Deleu,D., 2002
Valproate Embryopathy in Three Sets of Siblings: Further Proof of Hereditary Susceptibility
Neurol 59:630-633, Malm,H.,et al, 2002
The Teratogenicity of Anticonvulsant Drugs
NEJM 344:1132-1138, Holmes,L.B.,et al, 2001
Is Carbamazepine Teratogenic? A Prospective Controlled Study of 210 Pregnancies
Neurol 57:321-324, Diav-Citrin,O.,et al, 2001
Effect of Food on Absorption of Dilantin Kapseals and Mylan Extended Phenytoin Sodium Capsules
Neurol 57 582-589,571, Wilder,B.J.,et al, 2001
Effect of Food on the Bioavailability of 100-mg Dilantin Kapseals
Neurol 57:698-700,571, Cook,J.,et al, 2001
Managing Status Epilepticus
BMJ 320:953-954, Heafield,M.T.E., 2000
Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000
Focal Lesion in the Splenium of the Corpus Callosum in Epileptic Patients:Antiepileptic Drug Toxicity
AJNR 20:125-129,131, Kim,S.S.,et al, 1999
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis During First Weeks of Antiepileptic Therapy:A Case-Control Study
Lancet 353:2190-2194, Rzany,B.,et al, 1999
Phenobarbital Compared with Phenytoin for the Treatment of Neonatal Seizures
NEJM 341:485-489, Painter,M.J.,et al, 1999
Antiepileptic Drug Regimens and Major Congenital Abnormalities in the Offspring
Ann Neurol 46:739-746, Samren,E.B.,et al, 1999
Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998
Management Issues for Women with Epilepsy,A Review of the Literature
Neurol 51:949-956, Zahn,C.A.,et al, 1998
Analysis of Prenatal and Gestational Care Given to Women with Epilepsy
Neurol 51:1039-1045, Seale,C.G.,et al, 1998
Practice Parameter,Management Issues for Women with Epilepsy (Summary Statement)
Neurol 51:944-948, Rpt of the Quality Stnds Subcmte AAN, 1998
Incidence and Clinical Consequence of the Purple Glove Syndrome in Patients Receiving Intravenous Phenytoin
Neurol 51:1034-1039,942, O'Brien,T.J.,et al, 1998
Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998
Status Epilepticus
NEJM 338:970-976, Lowenstein,D.H.&Alldredge,B.K., 1998
Drug-Induced Pseudolymphoma Secondary to Lamotrigine
Neurol 50:1509-1510, Pathak,P.&McLachlan,R.S., 1998
Use of Anticonvul in Eclampsia & Pre-Eclampsia:Survey of Obstetr in the UK & Rep of Ireland
BMJ 316:975-976, Gulmezoglu,A.M.&Duley,L., 1998
A Comparison of Four Treatments for Generalized Convulsive Status Epilepticus
NEJM 339:792-798, Treiman,D.M.,et al, 1998
Parenteral Fosphenytoin:Efficacy and Economic Considerations
The Neurologist 4:S30-S34, Ramsay,R.E.&Wilder,B.J., 1998
Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997
Color Vision Test for Early Detection of Antiepileptic Drug Toxicity
Neurol 48:1394-1397, Bayer,A.U.,et al, 1997
Risk of Serious Cutaneous Disorders after Initiation of Use of Phenytoin, Carbamazepine, or Sodium Valproate
Neurol 49:542-546, Tennis,P.&Stern,R.S., 1997
A Pharmacoeconomic Eval of IV Fosphenytoin (Cerebyx) vs IV Phenytoin (Dilantin) in Hosp ER Dept
Clin Therapeutics 18:953-966, Marchetti,A.,et al, 1996
Status Epilepticus in Children with Epilepsy:The Role of Antiepileptic Drug Levels in Prevention
Pediatrics 98:1119-1121, Maytal,J.,et al, 1996
Acute Phenytoin Toxicity Followed by Seizure Breakthrough From a Ticlopidine-Phenytoin Interaction
Arch Neurol 53:1191-1192, Privitera,M.&Welty,T.E., 1996
Antiepileptic Drugs
NEJM 334:168-175, Brodie,M.J.&Dichter,M.A., 1996
Ticlopidine Impairs Phenytoin Clearance:A Case Report
Neurol 46:1172-1173, Riva,R.,et al, 1996
Random Comp Monother Trial of Phenobarb, Phenytoin, Carbamazepine, or Sod Valp for Newly Dx Child Epilep
Lancet 347:709-713, deSilva,M.,et al, 1996
The Use of Parenteral Antiepileptic Drugs & The Role of Fosphenytoin
(Suppl Editor) , Neurol 46:S1-S2896., Wilder,B.J., 1996
Safety & Toler of Multi Doses of Intramusc Fosphenytoin Substi for Oral Phenytoin in Epilep or Neurosurg
Arch Neurol 53:764-768, Wilder,B.J.,et al, 1996
Phenytoin Neurotoxicity from Illicit Use
Neurol 45:198, Koppel,B.S.,et al, 1995
Phenobarbitone, Phenytoin, Carbamazepine, or Sodium Valproate for Newly Diagnosed Adult Epilepsy:A Randomized Monotherapy Trial
JNNP 58:44-50, Heller,A.J.,et al, 1995
Rational Polypharmacy in the Treatment of Epilepsy
(Ed) , Neurol (suppl) 45:S1-S38., Wilder,B.J., 1995
Which Anticonvulsant for Women with Eclampsia? Evidence from the Collaborative Eclampsia Trial
Lancet 345:1455-1463, Duley,L.,et al, 1995
A Comparison of Magnesium Sulfate with Phenytoin for the Prevention of Eclampsia
NEJM 333:201-205, 2501995., Lucas,M.J.,et al, 1995
Drugs for Epilepsy
The Medical Letter, 37:37-401995., , 1995
Comparative Cognitive Effects of Phenobarbital, Phenytoin, and Valproate in Healthy Adults
Neurol 45:1494-1499, Meador,K.J.,et al, 1995
Appropriateness of Antiepileptic Drug Level Monitoring
JAMA 274:1622-1626, Schoenenbergber,R.A.,et al, 1995
Anticonvulsant Hypersensitivity Syndrome
Arch Int Med 155:2285-2290, Vittorio,C.C.&Muglia,J.J., 1995
The Nondystrophic Myotonias
In Myology, McGraw-Hill, 2nd Ed, Ch49, p1291-13024., Rudel,R.,et al, 1994
Status Epilepticus and Antiepileptic Medication Levels
Neurol 44:47-50, Barry,E.&Hauser,W.A., 1994